1 Market Overview
1.1 Product Overview and Scope of Neuroblastoma Drugs
1.2 Classification of Neuroblastoma Drugs by Type
1.2.1 Overview: Global Neuroblastoma Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Neuroblastoma Drugs Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Global Neuroblastoma Drugs Market by Application
1.3.1 Overview: Global Neuroblastoma Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neuroblastoma Drugs Market Size & Forecast
1.5 Global Neuroblastoma Drugs Market Size and Forecast by Region
1.5.1 Global Neuroblastoma Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Neuroblastoma Drugs Market Size by Region, (2016-2021)
1.5.3 North America Neuroblastoma Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Neuroblastoma Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Neuroblastoma Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Neuroblastoma Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Neuroblastoma Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuroblastoma Drugs Market Drivers
1.6.2 Neuroblastoma Drugs Market Restraints
1.6.3 Neuroblastoma Drugs Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Neuroblastoma Drugs Product and Solutions
2.1.4 Pfizer Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Teva Pharmaceutical
2.2.1 Teva Pharmaceutical Details
2.2.2 Teva Pharmaceutical Major Business
2.2.3 Teva Pharmaceutical Neuroblastoma Drugs Product and Solutions
2.2.4 Teva Pharmaceutical Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Teva Pharmaceutical Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Neuroblastoma Drugs Product and Solutions
2.3.4 Johnson & Johnson Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Neuroblastoma Drugs Product and Solutions
2.4.4 Bristol-Myers Squibb Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 United Therapeutics
2.5.1 United Therapeutics Details
2.5.2 United Therapeutics Major Business
2.5.3 United Therapeutics Neuroblastoma Drugs Product and Solutions
2.5.4 United Therapeutics Neuroblastoma Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 United Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neuroblastoma Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Neuroblastoma Drugs Players Market Share
3.2.2 Top 10 Neuroblastoma Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Neuroblastoma Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Neuroblastoma Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Neuroblastoma Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Neuroblastoma Drugs Revenue Market Share by Application (2016-2021)
5.2 Neuroblastoma Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Neuroblastoma Drugs Revenue by Type (2016-2026)
6.2 North America Neuroblastoma Drugs Revenue by Application (2016-2026)
6.3 North America Neuroblastoma Drugs Market Size by Country
6.3.1 North America Neuroblastoma Drugs Revenue by Country (2016-2026)
6.3.2 United States Neuroblastoma Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Neuroblastoma Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Neuroblastoma Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Neuroblastoma Drugs Revenue by Type (2016-2026)
7.2 Europe Neuroblastoma Drugs Revenue by Application (2016-2026)
7.3 Europe Neuroblastoma Drugs Market Size by Country
7.3.1 Europe Neuroblastoma Drugs Revenue by Country (2016-2026)
7.3.2 Germany Neuroblastoma Drugs Market Size and Forecast (2016-2026)
7.3.3 France Neuroblastoma Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Neuroblastoma Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Neuroblastoma Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Neuroblastoma Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Neuroblastoma Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Neuroblastoma Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Neuroblastoma Drugs Market Size by Region
8.3.1 Asia-Pacific Neuroblastoma Drugs Revenue by Region (2016-2026)
8.3.2 China Neuroblastoma Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Neuroblastoma Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Neuroblastoma Drugs Market Size and Forecast (2016-2026)
8.3.5 India Neuroblastoma Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Neuroblastoma Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Neuroblastoma Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Neuroblastoma Drugs Revenue by Type (2016-2026)
9.2 South America Neuroblastoma Drugs Revenue by Application (2016-2026)
9.3 South America Neuroblastoma Drugs Market Size by Country
9.3.1 South America Neuroblastoma Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Neuroblastoma Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Neuroblastoma Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Neuroblastoma Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Neuroblastoma Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Neuroblastoma Drugs Market Size by Country
10.3.1 Middle East & Africa Neuroblastoma Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Neuroblastoma Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Neuroblastoma Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Neuroblastoma Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Pfizer、Teva Pharmaceutical、Johnson & Johnson、Bristol-Myers Squibb、United Therapeutics
【免責事項】
https://www.globalresearch.jp/disclaimer